Gunderson Dettmer represented client Geltor, a biodesign startup, in its $91.3 million Series B financing led by CPT Capital with significant commitment from WTT Investment Ltd., to expand its ingredients-as-a-service platform globally.

In the announcement of the transaction CEO of Geltor Alex Lorestani said, “This next stage of growth will allow Geltor to meet the moment our world is facing, as businesses recognize the urgent need to transition to a sustainable protein supply chain.”

The Gunderson deal team was led by Bennett Yee and included Damon Zhangchai, John Paul Karas, Olga Zolotnik and Kelly Trimble.